series-a
Stage
2020
Founded
3
Investors
About
A preclinical-stage biotechnology company developing novel medicines to eliminate senescent cells, which are a key driver of multiple age-related diseases.
Explore Deciduous Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.